Versigent (NYSE:VGNT - Get Free Report) was upgraded by equities research analysts at UBS Group to a "strong-buy" rating in a report released on Tuesday, MarketBeat Ratings reports.
VGNT has been the topic of a number of other reports. Royal Bank Of Canada started coverage on Versigent in a research report on Tuesday, March 31st. They issued a "sector perform" rating and a $28.00 target price on the stock. Wells Fargo & Company began coverage on Versigent in a research report on Monday, April 6th. They set an "overweight" rating and a $35.00 price objective on the stock. TD Cowen began coverage on Versigent in a research report on Tuesday. They set a "buy" rating and a $47.00 price objective on the stock. Finally, Fox Advisors upgraded Versigent to a "strong-buy" rating in a research report on Tuesday, April 7th. Three investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat, Versigent currently has an average rating of "Buy" and an average price target of $38.25.
View Our Latest Research Report on Versigent
Versigent Price Performance
NYSE:VGNT opened at $32.98 on Tuesday. Versigent has a 12 month low of $26.34 and a 12 month high of $34.99.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Versigent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Versigent wasn't on the list.
While Versigent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead.
This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
